Literature DB >> 2447279

Potent, long-acting luteinizing hormone-releasing hormone antagonists containing new synthetic amino acids: N,N'-dialkyl-D-homoarginines.

J J Nestor1, R Tahilramani, T L Ho, G I McRae, B H Vickery.   

Abstract

A new series of unnatural amino acids has been prepared and incorporated into antagonistic analogues of luteinizing hormone-releasing hormone (LH-RH), on the basis of the hypothesis that stabilization of a proposed phospholipid membrane interaction might yield analogues with high potency and a prolonged duration of action. Thus a series of NG,NG'-dialkyl-D-homoarginine analogues [H-D-hArg(R2)-OH; R = Me, Et, Pr, i-Pr, Bu, hexyl, cyclohexyl, (Et, Me2NPr)] was conveniently prepared by semisynthesis from D-Lys using the appropriate dialkylcarbodiimide. A number of the analogues that were prepared by using these new amino acid analogues exhibited very high potency and a prolonged duration of action. One of the most potent members of the series, [N-Ac-D-Nal(2)1,D-pCl-Phe2,D-Trp3,D-hArg(Et2)6,D-Ala10 ]LH-RH (detirelix), had an ED50 of 0.7 microgram in the rat antiovulatory assay when administered at noon on proestrus and only 2.5 micrograms when administered 24 h earlier, at noon on diestrus II. This antagonist is undergoing detailed biological and clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2447279     DOI: 10.1021/jm00396a011

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Processing of Alzheimer's disease-associated beta-amyloid precursor protein.

Authors:  N N Dewji; E R Shelton; M J Adler; H W Chan; J E Seegmiller; C Coronel
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

2.  Antide and related antagonists of luteinizing hormone release with long action and oral activity.

Authors:  A Ljungqvist; D M Feng; W Hook; Z X Shen; C Bowers; K Folkers
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Increased gene expression of Alzheimer disease beta-amyloid precursor protein in senescent cultured fibroblasts.

Authors:  M J Adler; C Coronel; E Shelton; J E Seegmiller; N N Dewji
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

4.  Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.

Authors:  Dimitrios Tsikas; Alexander Bollenbach; Erik Hanff; Arslan Arinc Kayacelebi
Journal:  Cardiovasc Diabetol       Date:  2018-01-04       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.